Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial-Reference-Cited by-同舟云学术

Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial

Published:2009-09-03 Issue:1 Volume:9 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Vansteenkiste Johan,Hedenus Michael,Gascon Pere,Bokemeyer Carsten,Ludwig Heinz,Vermorken Jan,Hamilton Lisa,Bridges Ken,Pujol Beatriz

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/article/10.1186/1471-2407-9-311/fulltext.html

Reference32 articles.

1. Groopman JE, Itri LM: Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst. 1999, 91 (19): 1616-1634. 10.1093/jnci/91.19.1616.

2. Cella D, Dobrez D, Glaspy J: Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes. Ann Oncol. 2003, 14 (4): 511-519. 10.1093/annonc/mdg167.

3. Barbara JA: The rationale for pathogen-inactivation treatment of blood components. Int J Hematol. 2004, 80 (4): 311-316. 10.1532/IJH97.04120.

4. Looney MR, Gropper MA, Matthay MA: Transfusion-related acute lung injury: a review. Chest. 2004, 126 (1): 249-258. 10.1378/chest.126.1.249.

5. Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH: Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med. 2008, 168 (21): 2377-2381. 10.1001/archinte.168.21.2377.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous iron versus oral iron versus no iron with or without erythropoiesis- stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-06-20

2. Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status;Clinical Colorectal Cancer;2018-03

3. Transfusion practice patterns in patients with anemia receiving myelosuppressive chemotherapy for nonmyeloid cancer: results from a prospective observational study;Supportive Care in Cancer;2018-01-19

4. The impact of chemotherapy-associated hemoglobin on prognosis of colorectal cancer patients receiving adjuvant chemotherapy;Cancer Biomarkers;2017-12-06

5. Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia;Cancer Medicine;2016-11-23